These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6740563)

  • 1. Antithrombic properties of insoluble modified polystyrene: Part I.
    Boisson C; Gulino D; Jozefonvicz J; Fischer AM; Tapon-Bretaudiere J
    Thromb Res; 1984 May; 34(4):269-76. PubMed ID: 6740563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombin binding properties of insoluble modified polystyrene: Part II.
    Fischer AM; Tapon-Bretaudiere J; Bros A; Boisson C; Gulino D; Jozefonvicz J
    Thromb Res; 1988 Apr; 50(2):317-24. PubMed ID: 3260695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affinity of antithrombin III for insoluble modified polystyrene.
    Boisson C; Gulino D; Jozefonvicz J
    Thromb Res; 1987 Apr; 46(1):101-8. PubMed ID: 3590108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affinity of purified thrombin or antithrombin III for two insoluble anticoagulant polystyrene derivatives: I. In vitro adsorption studies.
    Fougnot C; Jozefowicz M; Rosenberg RD
    Biomaterials; 1983 Oct; 4(4):294-8. PubMed ID: 6640057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adsorption of thrombin from buffer and modified plasma to polystyrene resins containing sulphonate and sulphamide arginyl methyl ester groups.
    Boisson C; Jozefonvicz J; Brash JL
    Biomaterials; 1988 Jan; 9(1):47-52. PubMed ID: 3349121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affinity chromatography of thrombin on modified polystyrene resins.
    Yu XJ; Fischer AM; Muller D; Bros A; Tapon-Bretaudiere J; Jozefonvicz J
    J Chromatogr; 1986 Apr; 376():429-35. PubMed ID: 3711199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of anticoagulant insoluble modified polystyrene resins with plasmatic proteins.
    Fougnot C; Jozefowicz M; Bara L; Samama M
    Thromb Res; 1982 Oct; 28(1):37-46. PubMed ID: 7157229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-performance affinity chromatography of human thrombin on modified polystyrene resins.
    Muller D; Yu XJ; Fischer AM; Bros A; Jozefonvicz J
    J Chromatogr; 1986 May; 359():351-7. PubMed ID: 3733936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adsorption of purified thrombin or antithrombin III for two insoluble anticoagulant polystyrene derivatives: II. Competition with the other plasma proteins.
    Fougnot C; Jozefowicz M; Rosenberg RD
    Biomaterials; 1984 Mar; 5(2):89-93. PubMed ID: 6722254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catalysis of the generation of thrombin-antithrombin complex by insoluble anticoagulant polystyrene derivatives.
    Fougnot C; Jozefowicz M; Rosenberg RD
    Biomaterials; 1984 Mar; 5(2):94-9. PubMed ID: 6722255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin purification by one-step preparative affinity chromatography on modified polystyrenes.
    Fischer AM; Yu XJ; Tapon-Bretaudiere J; Muller D; Bros A; Jozefonvicz J
    J Chromatogr; 1986 Aug; 363(1):95-100. PubMed ID: 3093512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New heparin-like insoluble materials: part I.
    Fougnot C; Jozefonvicz J; Samama M; Bara L
    Ann Biomed Eng; 1979; 7(5-6):429-39. PubMed ID: 549502
    [No Abstract]   [Full Text] [Related]  

  • 13. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
    Weitz JI; Hudoba M; Massel D; Maraganore J; Hirsh J
    J Clin Invest; 1990 Aug; 86(2):385-91. PubMed ID: 2384594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a pentosan polysulphate upon thrombin and factor Xa inactivation by antithrombin III.
    Scully MF; Kakkar VV
    Biochem J; 1984 Sep; 222(3):571-8. PubMed ID: 6207810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmatic antiproteinase activity enhancement by insoluble functionalized polystyrene surfaces.
    Charef S; Jozefowicz M; Labarre D; Tapon-Bretaudiere J; Fischer AM; Bros A
    Biomaterials; 1990 Aug; 11(6):425-9. PubMed ID: 2207233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a heparan sulphate with high affinity for antithrombin III upon inactivation of thrombin and coagulation factor Xa.
    Scully MF; Ellis V; Shah N; Kakkar V
    Biochem J; 1989 Sep; 262(2):651-8. PubMed ID: 2529852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S protein modulates the heparin-catalyzed inhibition of thrombin by antithrombin III. Evidence for a direct interaction of S protein with heparin.
    Preissner KT; Müller-Berghaus G
    Eur J Biochem; 1986 May; 156(3):645-50. PubMed ID: 3699029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reaction of thrombins with human antithrombin III. I. Enzyme activity losses unrelated to the inhibitory reaction and their prevention.
    Latallo ZS; Hall JA
    Thromb Res; 1986 Sep; 43(5):507-21. PubMed ID: 3750277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Hereditary Thrombophilia: Performance of Antithrombin (AT) Testing.
    Gausman JN; Marlar RA
    Methods Mol Biol; 2017; 1646():161-167. PubMed ID: 28804827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.